SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-19-024814
Filing Date
2019-04-16
Accepted
2019-04-16 18:41:55
Documents
2
Period of Report
2019-04-16

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 6267
2 POA DOCUMENT poa.txt EX-24.3_847910 3041
  Complete submission text file 0001209191-19-024814.txt   10904
Mailing Address C/O AMBIT BIOSCIENCES CORPORATION 11080 ROSELLE STREET SAN DIEGO CA 92121
Business Address
Countouriotis Athena (Reporting) CIK: 0001571469 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38871 | Film No.: 19751892

Mailing Address 10628 SCIENCE CENTER DRIVE, SUITE 225 SAN DIEGO CA 92121
Business Address 10628 SCIENCE CENTER DRIVE, SUITE 225 SAN DIEGO CA 92121 858-926-5251
Turning Point Therapeutics, Inc. (Issuer) CIK: 0001595893 (see all company filings)

IRS No.: 463826166 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations